Publications

Biotech Millionaire

Biotech Millionaire

Cost
Paid
Parent Entity
Frequency
Monthly, Weekly
Published
2018

Biotech Millionaire is a premium newsletter focused on small-cap medical biotech stocks with exceptional short- to mid-term profit potential. Their unique C.A.S.H. investing formula—Catalyst, Addressable Market, Science, Hype Potential—ensures that only the most promising candidates make it into the Biotech Millionaire portfolio. They also feature pre-revenue companies with promising pipeline candidates in clinical trials, with the goal for each portfolio stock to get at least a 100% return in the span of 12 to 24 months. Editor Chris Wood also edits the “entry level” healthcare investment advisory Healthy Returns.

Upon subscription, Biotech Millionaire will provide you with:

  • Timely trade alerts whenever fast-moving events present the opportunity to Buy, Sell, or Take Profits
  • Monthly deep-dive analysis with a new stock recommendation, plus a full portfolio review
  • LIVE portfolio with real-time Buy/Sell alerts
  • Weekly updates on the Biotech Millionaire portfolio companies and new developments in the sector
  • Full access to all special reports and archived issues